Stem cells in regenerative medicine
Subtitle: science, regulation and business strategies
By: edited by Alain Vertes, Nasib Qureshi, Arnold Caplan, Lee Babiss
Publisher: John Wiley & Sons, Ltd
Published: 2015
Place of publication: Hoboken, NJ
Language: eng
ISBN-13: 9781119971399
Subjects: Stem cells; Regenerative medicine
Notes: Includes bibliographical references and index.
Table of contents: title: Therapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes; title: Ethical considerations on the research and business of stem cells / Ljiljana Minwalla; title: Projected growth of the worldwide stem cell market / Ed Field; title: Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith; title: The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson; title: Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber; title: The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies; title: The business of stem cell research tools / Erik Miljan; title: Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine; title: Stem cell tools for compound development / Tom Novak; title: Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar; title: The market of stem cell medicines for domestic and high value animals / Bob J. Harmann; title: Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone; title: Stem cells in veterinary medicines: a practical approach / Bob J. Harmann; title: Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes; title: Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr.; title: Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra; title: Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller; title: Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu; title: Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss; title: Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati; title: Hematopoietic stem cells / Steve Wolpe and Lynnet Koh; title: MSCs: the new medicince / Arnold Caplan; title: Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku; title: Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving; title: Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar; title: Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi; title: Challenges in the clinical development of stem cells / John Caulfield; title: Pricing and reimbursement of regenerative medicines / Nathan Dowden; title: The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo; title: Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio; title: Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith; title: History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden; title: Deployment of stem cell technologies in industry and healthcare/ Alain Vertes.